Engineering the Future of Medicine — One Cell at a Time
Welcome to the ATMP Conference 2025 — a premier European forum bringing together pioneers in cell, gene, and tissue-engineered therapies. Across two impactful days, we explore the regulatory, scientific, and commercial frontiers of ATMPs, focusing on innovation, clinical translation, and access. Join us in Barcelona this November to connect with leaders shaping the future of personalized, regenerative, and curative medicine
6 Key Themes for the ATMP Conference 2025
6 Key Themes for the ATMP Conference 2025
- Gene & Cell Therapy Development: Advances in ex vivo/in vivo gene editing, CAR-T, TCR-T, and stem cell technologies.
- Manufacturing & Scale-Up: Next-gen GMP manufacturing platforms, automation, and decentralized models.
- Clinical Trials & Translational Science: Innovative trial design, biomarkers, and patient-centered approaches.
- Regulatory Frameworks & Approvals: Navigating EMA, FDA, and HTA pathways for faster, safer ATMP access.
- Access, Reimbursement & Health Economics: From pricing models to value-based outcomes and market entry strategies.
- Hospital Exemption & Academic Innovation: Non-commercial ATMPs and public-sector pathways for treatment innovation.
The ATMP Conference 2025
Join leading scientists, biotechs, pharma innovators, regulators, and investors at the ATMP Conference 2025—a key meeting point for advancing the next generation of cell, gene, and tissue-based therapies.
Key Benefits:
- Network with global ATMP leaders in a high-impact, collaborative environment
- Discover cutting-edge breakthroughs in cell and gene therapies, tissue engineering, CRISPR, and mRNA platforms
- Engage with regulators and policy experts to stay ahead of evolving EU and international frameworks
- Explore clinical and commercial strategies that are shaping the future of advanced therapies
- Identify partnering and funding opportunities with investors and pharma strategics focused on ATMP development
